Thermo Fisher Scientific Expands its Global Biologics and Steriles Manufacturing Capabilities in China
Located at the heart of Belgium’s largest biotech hub, our facilities in Seneffe, Belgium are dedicated to clinical and commercial viral vector production, fill/finish and manufacturing.
Our unique configuration makes it possible to have both production and fill/finish operations on the same site and guarantees the highest reliability and performance of our manufacturing services to secure the supply of innovative therapies.
The clinical and commercial manufacturing facility spans 2,000m2 (21,500 sq. ft.) and meets the highest standards governing commercial production for biopharmaceutical use. A zero-risk approach thus remains a core priority with the separation of different production zones and effluent and material onsite decontamination.
It features two cGMP production lines: one dedicated to adherence cell culture for viral vectors in moderate quantities–to treat certain rare diseases or for lower dose indications–and one for suspension cell culture with bioreactors of 50 to 2,000 liters to produce larger quantities. This equipment is designed to meet the growing demand of biopharmaceutical companies worldwide.
The fill/finish facility features state-of-the-art semi-automatic and automatic liquid filling machines under isolator and can deliver up to 10,000 vials per session, with 2-3 sessions per week. Quality Control and visual inspections are carried out by highly qualified technicians.